Search research articles
Contact Us
Filters
Showing results (61-70 of 97) with videos related to
Page
of 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2011
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar, Mathew Simcock, Gabriela Studer, et al.
European Journal of Applied Physiology
|
January 7, 2010
Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers
Cora Stefanie Weber, Julian F Thayer, Miriam Rudat, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 6, 2021
Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study
Alexandros Papachristofilou, Tobias Finazzi, Andrea Blum, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2021
Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study
Alexandros Papachristofilou, Tobias Finazzi, Andrea Blum, et al.
Cancer
|
April 12, 2006
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas
Björn L D M Brücher, Karen Becker, Florian Lordick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 8, 2005
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects
Gregor Goldner, Frank Zimmermann, Horst Feldmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 26, 2009
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial
Gregor Goldner, Valentin Bombosch, Hans Geinitz, et al.
Wiener Klinische Wochenschrift
|
June 24, 2006
3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment
Gregor Goldner, Hans Geinitz, Stefan Wachter, et al.
Blood Advances
|
January 4, 2018
T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasia
Tina Rubic-Schneider, Masataka Kuwana, Brigitte Christen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2004
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
Hinrich A Wieder, Björn L D M Brücher, Frank Zimmermann, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 97) with videos related to
Sort By:
Page
of 10
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2011
Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94)
Pirus Ghadjar, Mathew Simcock, Gabriela Studer, et al.
European Journal of Applied Physiology
|
January 7, 2010
Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers
Cora Stefanie Weber, Julian F Thayer, Miriam Rudat, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 6, 2021
Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study
Alexandros Papachristofilou, Tobias Finazzi, Andrea Blum, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2021
Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study
Alexandros Papachristofilou, Tobias Finazzi, Andrea Blum, et al.
Cancer
|
April 12, 2006
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas
Björn L D M Brücher, Karen Becker, Florian Lordick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 8, 2005
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects
Gregor Goldner, Frank Zimmermann, Horst Feldmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 26, 2009
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial
Gregor Goldner, Valentin Bombosch, Hans Geinitz, et al.
Wiener Klinische Wochenschrift
|
June 24, 2006
3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment
Gregor Goldner, Hans Geinitz, Stefan Wachter, et al.
Blood Advances
|
January 4, 2018
T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasia
Tina Rubic-Schneider, Masataka Kuwana, Brigitte Christen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2004
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment
Hinrich A Wieder, Björn L D M Brücher, Frank Zimmermann, et al.
Page
of 10